FDA Approves New Biological Drug for Rheumatoid Arthritis

WEDNESDAY, Aug. 31, 2016 -- A new biological drug to treat rheumatoid arthritis and other inflammatory diseases has been approved by the U.S. Food and Drug Administration. The drug Erelzi (etanercept-szzs) is a " biosimilar " to Enbrel (etanercept),...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news